Aurinia Pharmaceuticals Inc (AUPH) Directors and Executive Officers - CSIMarket
CSIMarket
 
Aurinia Pharmaceuticals Inc   (NASDAQ: AUPH)

Aurinia Pharmaceuticals Inc

Officers & Directors


Executives:

- Peter Greenleaf: Chief Executive Officer and Director. Mr. Greenleaf has more than 25 years of experience in the pharmaceutical industry, having held executive positions at several companies including MedImmune, Centocor, and Medco Health Solutions.

- Joseph Miller: Chief Financial Officer.

Directors:

- Daniel Billen: Chairman of the Board.

- R. Hector MacKay-Dunn: Director.

- Dr. Karen Smith: Director.

- Jill Leversage: Director.

- Dr. Robert T. Foster: Director.

- Jeffrey A. Bailey: Director.

- David R.W. Jayne: Director.

- Brinda Balakrishnan: Director.

- Chartered Professional Accountants, Licensed Public Accountants, Toronto, Canada.,

Aurinia Pharmaceuticals Inc currently has 128 employees.






AUPH Management Effectiveness AUPH Revenue per Employee AUPH Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.